ATX 3 308 0,1%  Dow 24 509 -0,3%  Nasdaq 6 390 -0,1%  Euro 1,1779 0,1% 
ATX P 1 671 0,1%  EStoxx50 3 556 -0,7%  Nikkei 22 614 -0,4%  CHF 1,1646 0,0% 
DAX 13 068 -0,4%  FTSE100 7 448 -0,7%  Öl 63,4 1,0%  Gold 1 254 0,2% 

Neos Therapeutics Aktie [WKN DE: A14XHH / ISIN: US64052L1061]

28.11.2017 14:00:00

Neos Therapeutics to Participate in Two December Conferences


DALLAS and FORT WORTH, Texas, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally disintegrating tablet (ODT) technology platforms, today announced that management will participate in two upcoming conferences in December.
Weiter zum vollständigen Artikel bei "Globe Newswire (RSS)"

Analysen zu Neos Therapeutics Inc

mehr Analysen
  • Alle
  • Buy
  • Hold
  • Sell
09.08.17 Neos Therapeutics Outperform RBC Capital Markets
01.08.17 Neos Therapeutics Overweight Cantor Fitzgerald
20.03.17 Neos Therapeutics Neutral UBS AG
17.05.16 Neos Therapeutics Outperform RBC Capital Markets

Eintrag hinzufügen

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten
pagehit